The University of Chicago Header Logo

Jennifer Cooperrider

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentMedicine-Hematology and Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cooperrider JH, Derman BA. Minimal Residual Disease Negativity as the Primary Goal of Multiple Myeloma Therapy. Drugs. 2025 Oct; 85(10):1231-1251. PMID: 40908381; PMCID: PMC12484384.
      Citations: 1     Fields:    Translation:Humans
    2. Derman BA, Cooperrider J, Pula A, Simmons H, Kubicki T, Zonder J, Afrough A, Grinblatt D, Rosenblatt J, Anderson LD, Kin A, Avigan D, Narula S, Rayani S, Jiang K, Major A, Karrison T, Jacob A, Jakubowiak AJ. Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant. Hemasphere. 2025 Aug; 9(8):e70186. PMID: 40838100; PMCID: PMC12361927.
      Citations:    
    3. Kelly K, Cooperrider J, Bishop MR, Kosuri S, Jakubowiak A, Derman BA, Kelly K, Cooperrider JH, Bishop MR, Kosuri S, Jakubowiak A, Derman BA. Intrathecal chemotherapy for ciltacabtagene autoleucel-associated movement and neurocognitive toxicity. Blood Adv. 2025 Jul 22; 9(14):3613-3616. PMID: 40334078; PMCID: PMC12281119.
      Citations: 2     Fields:    
    4. Cooperrider JH, Karaoglu DA, Kubicki T, Jiang CR, Postich E, Shimamoto K, Arnold O, Macaraeg J, Ramsland A, Pula A, Kishtagari A, Pershad Y, Mack TM, Jones A, Bick AG, Savona M, Drazer MW, Dytfeld D, Jakubowiak A, Derman BA, Saygin C. Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma. Leukemia. 2025 Sep; 39(9):2285-2288. PMID: 40670674; PMCID: PMC12380616.
      Citations: 3     Fields:    
    5. Kubicki T, Derman BA, Cooperrider JH, Pula A, Barnidge D, Dytfeld D, Jiang K, Jakubowiak AJ. Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma. Blood Neoplasia. 2025 Nov; 2(4):100124. PMID: 40919481; PMCID: PMC12409812.
      Citations: 1     Translation:CTClinical Trials
    6. Grischke TK, Cooperrider JH, Pula A, Sneider A, Yates S, Jakubowiak AJ, Derman BA. Brain-to-vein and vein-to-vein times and outcomes in CAR T-cell therapy in myeloma. Blood Cancer J. 2025 Mar 28; 15(1):47. PMID: 40155599; PMCID: PMC11953295.
      Citations: 1     Fields:    
    7. Marable M, Kelly K, Cooperrider JH, Jakubowiak A, Derman BA. Rapid high-dose cyclophosphamide as bridging treatment for advanced therapies in multiple myeloma. EJHaem. 2024 Dec; 5(6):1260-1264. PMID: 39691273; PMCID: PMC11647735.
      Citations: 1     
    8. Derman BA, Major A, Cooperrider J, Jiang K, Ramsland A, Karrison T, Kubicki T, Jakubowiak AJ. Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP). Blood Cancer J. 2024 10 07; 14(1):170. PMID: 39375362; PMCID: PMC11458825.
      Citations: 14     Fields:    Translation:Humans
    9. Dytfeld D, Przybylowicz-Chalecka A, Jamroziak K, Tyczynska A, Nowicki A, Lojko-Dankowska A, Matuszak M, Konska A, Czabak O, Kubicki T, Barnidge D, Sakrikar D, Robak P, Czyz J, Druzd-Sitek A, Giannopoulos K, Wróbel T, Szczepaniak T, Gil L, Pula B, Szukalski L, Zaucha JM, Walewski J, Mikulski D, Robak T, Jiang K, Cooperrider JH, Jakubowiak AJ, Derman BA. Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma. Blood. 2024 08 29; 144(9):955-963. PMID: 38713888; PMCID: PMC11406170.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    10. Derman BA, Cooperrider J, Rosenblatt J, Avigan DE, Rampurwala M, Barnidge D, Major A, Karrison T, Jiang K, Ramsland A, Kubicki T, Jakubowiak AJ. Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant. Blood Cancer J. 2024 05 29; 14(1):87. PMID: 38811560; PMCID: PMC11136961.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    11. Cooperrider JH, Shukla N, Nawas MT, Patel AA. The Cup Runneth Over: Treatment Strategies for Newly Diagnosed Acute Myeloid Leukemia. JCO Oncol Pract. 2023 02; 19(2):74-85. PMID: 36223559; PMCID: PMC10476749.
      Citations: 7     Fields:    Translation:Humans
    12. Strohbehn GW, Cooperrider JH, Yang D, Fendrick AM, Ratain MJ, Zaric GS. Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance Plan. Value Health Reg Issues. 2022 Sep; 31:34-38. PMID: 35395499.
      Citations: 2     Fields:    Translation:Humans
    13. Stephens DM, Boucher K, Kander E, Parikh SA, Parry EM, Shadman M, Pagel JM, Cooperrider J, Rhodes J, Mato A, Winter A, Hill B, Gaballa S, Danilov A, Phillips T, Brander DM, Smith SM, Davids M, Rogers K, Glenn MJ, Byrd JC. Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration. Haematologica. 2021 11 01; 106(11):2845-2852. PMID: 33054118; PMCID: PMC8561295.
      Citations: 12     Fields:    Translation:Humans
    14. Cooperrider JH, Fulton N, Artz AS, Larson RA, Stock W, Kosuri S, Bishop M, Liu H. Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplant. 2020 11; 55(11):2204-2206. PMID: 32376970.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    15. Jennewein MF, Goldfarb I, Dolatshahi S, Cosgrove C, Noelette FJ, Krykbaeva M, Das J, Sarkar A, Gorman MJ, Fischinger S, Boudreau CM, Brown J, Cooperrider JH, Aneja J, Suscovich TJ, Graham BS, Lauer GM, Goetghebuer T, Marchant A, Lauffenburger D, Kim AY, Riley LE, Alter G. Fc Glycan-Mediated Regulation of Placental Antibody Transfer. Cell. 2019 06 27; 178(1):202-215.e14. PMID: 31204102; PMCID: PMC6741440.
      Citations: 129     Fields:    Translation:HumansCellsPHPublic Health
    16. Kroy DC, Ciuffreda D, Cooperrider JH, Tomlinson M, Hauck GD, Aneja J, Berger C, Wolski D, Carrington M, Wherry EJ, Chung RT, Tanabe KK, Elias N, Freeman GJ, de Kruyff RH, Misdraji J, Kim AY, Lauer GM. Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors. Gastroenterology. 2014 Feb; 146(2):550-61. PMID: 24148617; PMCID: PMC3946973.
      Citations: 54     Fields:    Translation:HumansCells
    Cooperrider's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (73)
    Explore
    _
    Co-Authors (16)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _